Table 1.
Characteristics of studies included in the meta-analysis on cancer and alcohol consumption
| Cancer type | No. of studies | Publication year |
Country |
Cohort size (range) |
Case size (range) |
Age at baseline, range (yr) | Year(s) of baseline, range | Outcome (no. of studies) | Duration of follow-up, range (yr) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | No. of studies | Geographical area | No. of studies | Male | Female | Male | Female | |||||||
| Esophageal cancer | 14 | Before 2010 | 7 | Asia | 12 | 2,696-919,199 | 3,595-1,280,296 | 11-42,756 | 3-773 | 40-80 | 1965-2004 | Death | 10 | 5-20.8 |
| Europe & Australia | 1 | |||||||||||||
| After 2010 | 7 | America | 1 | Incidence | 4 | |||||||||
| Africa | 0 | |||||||||||||
| Stomach cancer | 14 | Before 2010 | 6 | Asia | 10 | 2,696-919,199 | 3,595-1,280,296 | 64-3,452 | 44-821 | 18-66.6 | 1965-2004 | Death | 6 | 5-46 |
| Europe & Australia | 1 | |||||||||||||
| After 2010 | 8 | America | 3 | Incidence | 8 | |||||||||
| Africa | 0 | |||||||||||||
| Liver cancer | 10 | Before 2010 | 3 | Asia | 8 | 2,696-919,199 | 3,595-1,280,296 | 36-3,807 | 19-3,807 | 20-66.6 | 1965-2003 | Death | 7 | 5-20.8 |
| Europe & Australia | 1 | |||||||||||||
| After 2010 | 7 | America | 1 | Incidence | 3 | |||||||||
| Africa | 0 | |||||||||||||
| Pancreatic cancer | 16 | Before 2010 | 7 | Asia | 5 | 2,696-919,199 | 3,595-1,280,296 | 15-3,443 | 14-3,404 | 30-84 | 1972-2008 | Death | 6 | 5-24 |
| Europe & Australia | 5 | |||||||||||||
| After 2010 | 9 | America | 6 | Incidence | 10 | |||||||||
| Africa | 0 | |||||||||||||
| Colorectal cancer | 27 | Before 2010 | 14 | Asia | 13 | 2,682-5,105,889 | 3,595-3,654,706 | 26-64,476 | 16-36,569 | 18-75 | 1972-2005 | Death | 9 | 5-30 |
| Europe & Australia | 7 | |||||||||||||
| After 2010 | 13 | America | 7 | Incidence | 18 | |||||||||
| Africa | 0 | |||||||||||||
| Laryngeal cancer | 2 | Before 2010 | 1 | Asia | 1 | 919,199 | 1,280,296 | 49 | 138 | 48.3-55.9 | 1996-2001 | Death | 1 | 5-7.2 |
| Europe & Australia | 1 | |||||||||||||
| After 2010 | 1 | America | 0 | Incidence | 1 | |||||||||
| Africa | 0 | |||||||||||||
| Lung cancer | 20 | Before 2010 | 11 | Asia | 6 | 4,265-6,568,561 | 4,265-6,568,561 | 70-10,227 | 75-10,227 | 18-84 | 1965-2008 | Death | 10 | 5-32.8 |
| Europe & Australia | 4 | |||||||||||||
| After 2010 | 9 | America | 10 | Incidence | 10 | |||||||||
| Africa | 0 | |||||||||||||
| Thyroid cancer | 5 | Before 2010 | 3 | Asia | 0 | 55,040-292,101 | 69,153-1,280,296 | 170-172 | 169-421 | 41-62.55 | 1978-2001 | Death | 0 | 7.2-17.8 |
| Europe & Australia | 1 | |||||||||||||
| After 2010 | 2 | America | 4 | Incidence | 5 | |||||||||
| Africa | 0 | |||||||||||||
| Prostate cancer | 21 | Before 2010 | 14 | Asia | 3 | 3,775-919,199 | - | 46-17,227 | - | 18-84 | 1971-2008 | Death | 5 | 4-46 |
| Europe & Australia | 5 | |||||||||||||
| After 2010 | 7 | America | 13 | Incidence | 16 | |||||||||
| Africa | 0 | |||||||||||||
| Breast cancer | 36 | Before 2010 | 21 | Asia | 3 | - | 1,954-1,280,296 | - | 51-41,315 | 18-84 | 1959-2001 | Death | 5 | 1.99-28.5 |
| Europe & Australia | 13 | |||||||||||||
| After 2010 | 15 | America | 20 | Incidence | 31 | |||||||||
| Africa | 0 | |||||||||||||